Monday, September 25, 2017
 
 
Company News: Page (1) of 1 - 03/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Loyola University Chicago Appoints New Stritch School of Medicine Dean
Renowned Physician-Investigator, Educator, and Administrator, Steve A. N. Goldstein, MD, PhD, Appointed Dean
(March 17, 2017)

CHICAGO, March 17, 2017 /PRNewswire-USNewswire/ -- Loyola University Chicago announces the appointment of Steve A. N. Goldstein, MD, PhD, as dean of the Stritch School of Medicine following an extensive national search. Goldstein, who officially joins the University on May 1, has nearly 30 years of experience in health sciences research, medical education, and higher education administration.

He currently serves as university professor of biochemistry at Brandeis University. From 2011-2014, Dr. Goldstein was also provost and senior vice president for academic affairs. While at The University of Chicago from 2004-2011, he was a professor in many areas including pediatrics, cancer center, computational neuroscience, molecular medicine, neurobiology, and pharmacology and pharmacogenomics. Dr. Goldstein was also director of the Pediatrician-Scientist Training Program, chair of the Department of Pediatrics, founding director of the Institute of Molecular Pediatric Science, founding co-principal investigator and advisor of the Clinical and Translational Science Award-Institute for Translational Medicine, and founding physician-in-chief of the Comer Children's Hospital. From 1993-2004, Dr. Goldstein was on the faculty at Yale University where he rose to full professor and founded the Section of Developmental Biology and Biophysics.

"Throughout the interview process, we noted that Dr. Goldstein clearly shares our educational mission of preparing compassionate doctors," said Health Sciences Division Provost Margaret Faut Callahan, CRNA, PhD, FNAP, FAAN. "He also displayed a commitment to advancing our scholarship initiatives and high-impact translational research. Dr. Goldstein's proven leadership and collaborative skills will be of critical importance within Loyola, with our clinical partner Loyola University Health System and across Chicago's robust health care community and beyond."


At Brandeis University, Goldstein reorganized operations to improve services and decrease costs and implemented transparent, mission-based budgeting, which allowed academics to become a priority. This reorganization created the first balanced budget in a decade, along with new academic programs, faculty hires, and facilities. Goldstein also led the development of the Brandeis strategic plan, spearheaded diversity initiatives, directed major philanthropic initiatives, and introduced policies that resulted in the largest applicant pools and highest academic profiles in school history.

"It is a great honor to be joining the Stritch School of Medicine this spring," said Goldstein. "I am looking forward to working with the exceptional faculty, staff, and students and embarking on new endeavors in research and education that will advance Loyola's Jesuit, Catholic mission globally and in the local communities we serve."

Goldstein received a Doctor of Medicine and Doctor of Philosophy in Immunology from Harvard University. He holds a Master of Arts in Biochemistry from Brandeis University. His research interests involve ion channels and how they function in disease and health. This research has identified genetic and mechanistic bases for Sudden Infant Death Syndrome (SIDS) in African Americans, inherited and drug-induced cardiac arrhythmias, skeletal muscle disorders, and ischemic stroke. Goldstein's work has advanced methods in interventional cardiology and created diagnostic tests. He has also helped develop new techniques for translational investigations including real-time, single molecule spectroscopy and the creation of de novo neuropeptides based on natural products that target orphan receptions to treat disease.

Goldstein is a fellow of the American Academy of Pediatrics. In 2001, he received the prestigious E. Mead Johnson Award from the Society of Pediatrics for his research contributions. He previously served as a scientific advisor to the National Institutes of Health for Nanomedicine and is currently vice chair of the National Science Foundation Advisory Committee for Biological Sciences.

Contact:
Megan Troppito
Loyola University Chicago Health Sciences Division
708-216-5972
[email protected]

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/loyola-university-chicago-appoints-new-stritch-school-of-medicine-dean-300425699.html

SOURCE Loyola University Chicago

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medicine, Disease, Surgery, Medication, Childrens Health, Physician, Children, Science, Medical, Chemistry, Cancer, Science,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • The High-Tech Future of Home Healthcare
  • Global Spectroscopy Market (2017-2022): Analysis By Technology, Applications & Geography - Research and Markets
  • A Medical Implants Manufacturer Used Salesforce Effectiveness Solution to Improve Salesforce Performance Provided by Quantzig
  • Point of Care Technology Market :Company information, geographical data and Market Analysis
  • Dental Market Trends, Size, Growth, Leading Players, Opportunities and 2021 Global Analysis Forecasts Discussed in New Research Report

    Cancer
  • Targovax granted US Patent for mutant-RAS neoantigen platform lead products
  • Sonnet Biotherapeutics to present data on bispecific platform candidates at AACR and SITC Annual Meetings
  • RAD Technology Medical Systems Launches their Newest Product - Healing Portals
  • Cannabics Pharmaceuticals Files National Phase Applications for Its System and Method for High Throughput Screening of Cancer Cells
  • FACIT Congratulates Portfolio Company Fusion Pharmaceuticals on its US$46 Million Oversubscribed Series A
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines